State Specialty Directory
Hematology & Oncology in TX
Federal CMS data for 618 hematology & oncology providers across TX. Includes Medicare utilization, Open Payments industry funding, and PECOS enrollment status.
618
Providers
Median industry payments
$2,425
618
Hematology & Oncology Providers
in TX
$2,425
Median Industry Payments
per provider (2018–2024)
408
Median Medicare Services
fee-for-service claims
How to read this directory: Providers are listed by Medicare service volume, which reflects only
Medicare fee-for-service patients (typically 65+). This does not represent total practice volume.
Industry payments span multiple years and payment types — they are legal and do not indicate wrongdoing.
Hematology & Oncology includes multiple subspecialties with different practice patterns.
Learn more →
Showing top 50 of 618 providers, ranked by Medicare service volume. Search by city to narrow results.
Hematology & Oncology Providers — TX
NPPES · Open Payments · Medicare| Provider | City | Medicare Volume | Beneficiaries* | Top Procedure | Industry Payments | Payment Type | Coverage |
|---|---|---|---|---|---|---|---|
| REDDY, PRAVEEN MD | WICHITA FALLS | 409,300 | 9,315 | Iron infusion (Feraheme) | $6,282 (2018-2024) | Food & Beverage (52%) | Very High |
| ARANI, MOHSEN MD | THE WOODLANDS | 268,658 | 2,180 | Iron infusion (Injectafer) | $133,827 (2018-2024) | Consulting (55%) | Very High |
| DAGGUBATI, SREEDEVI MD | SAN ANTONIO | 254,565 | 7,984 | Azacitidine chemotherapy injection | $6,820 (2018-2024) | Food & Beverage (78%) | Very High |
| CASTILLO, RENE MD | AUSTIN | 243,953 | 5,905 | Iron infusion (Feraheme) | $952 (2018-2024) | Food & Beverage (65%) | Very High |
| FORERO, LEONARDO MD | AMARILLO | 205,722 | 3,557 | Iron infusion (Injectafer) | $18,177 (2018-2024) | Consulting (59%) | Very High |
| RIAZ, TALHA M.D. | WEATHERFORD | 195,234 | 1,357 | Iron infusion (Injectafer) | $3,772 (2018-2024) | Food & Beverage (93%) | Very High |
| RAIZEN, YUVAL MD | HOUSTON | 185,531 | 2,364 | Iron infusion (Feraheme) | $6,344 (2018-2024) | Food & Beverage (96%) | Very High |
| SUKI, SAMER MD | KINGWOOD | 183,383 | 1,902 | Iron infusion (Injectafer) | $17,910 (2018-2024) | Food & Beverage (88%) | Very High |
| KHOURY, PIERRE MD | KINGWOOD | 180,189 | 1,834 | Iron infusion (Injectafer) | $41,498 (2018-2024) | Food & Beverage (77%) | Very High |
| FLEENER, ERIN M.D. | BRYAN | 153,105 | 2,917 | Iron infusion (Feraheme) | $11,809 (2018-2024) | Food & Beverage (86%) | Very High |
| RIEBER, ALYSSA M.D. | FREDERICKSBURG | 149,797 | 5,307 | Darbepoetin injection (Aranesp) for anemia | $1,205 (2018-2024) | Food & Beverage (59%) | Very High |
| SHENKENBERG, TODD M.D. | HARLINGEN | 140,220 | 5,226 | Iron sucrose injection (Venofer) | $23,687 (2018-2024) | Food & Beverage (94%) | Very High |
| FARIDI, AMIR M.D. | DENISON | 137,445 | 5,514 | Iron infusion (Feraheme) | $56,926 (2018-2024) | Consulting (73%) | Very High |
| FLOYD, MARK MD | BRYAN | 135,684 | 2,164 | Iron infusion (Injectafer) | $8,782 (2018-2024) | Food & Beverage (94%) | Very High |
| OCHS, ANN-MARGARET D. O. | WEATHERFORD | 132,256 | 3,025 | Iron infusion (Feraheme) | $897 (2018-2024) | Food & Beverage (96%) | Very High |
| BEERAM, SRIDHAR MD | SAN ANTONIO | 131,964 | 4,663 | Darbepoetin injection (Aranesp) for anemia | $51,121 (2018-2024) | Consulting (63%) | Very High |
| PATEL, URMEEL M.D. | SHENANDOAH | 127,457 | 1,367 | Iron infusion (Injectafer) | $54,466 (2018-2024) | Consulting (48%) | Very High |
| SU, ANNIE M.D. | HOUSTON | 124,457 | 967 | Iron infusion (Feraheme) | $1,010 (2018-2024) | Food & Beverage (65%) | Very High |
| SHREEDHARA VASUDHA, MEERA MD | GREENVILLE | 123,889 | 1,988 | Iron sucrose injection (Venofer) | $1,827 (2018-2024) | Device Loan (60%) | Very High |
| SIDDA, ADARSH M.D. | DENISON | 116,467 | 3,874 | Iron infusion (Feraheme) | $1,817 (2018-2024) | Food & Beverage (52%) | Very High |
| KLEINBAUM, ERIC M.D. | HOUSTON | 114,931 | 1,784 | Iron infusion (Injectafer) | $6,138 (2018-2024) | Food & Beverage (95%) | Very High |
| MANSOOR, SHADAN M.D. | BURLESON | 108,742 | 1,644 | Iron infusion (Injectafer) | $2,820 (2018-2024) | Food & Beverage (99%) | Very High |
| KOVOOR, ANDREW MD | PLANO | 108,471 | 3,688 | Iron infusion (Feraheme) | $11,639 (2018-2024) | Food & Beverage (49%) | Very High |
| PAGE, RAY D.O. | WEATHERFORD | 107,197 | 1,559 | Iron infusion (Injectafer) | $48,461 (2018-2024) | Consulting (51%) | Very High |
| BAJAJ, KELASH MD | ODESSA | 106,815 | 4,642 | Iron sucrose injection (Venofer) | $622 (2018-2023) | Food & Beverage (89%) | Very High |
| SHRIKHANDE, SHUBHADA MD | AUSTIN | 104,488 | 5,374 | Anti-nausea injection (fosaprepitant) | $1,277 (2018-2024) | Food & Beverage (98%) | Very High |
| KALTER, STEVEN M.D. | SAN ANTONIO | 103,534 | 5,647 | Iron infusion (Injectafer) | $30,595 (2018-2024) | Food & Beverage (91%) | Very High |
| NGUYEN, ALEX M. D. | HOUSTON | 103,285 | 1,535 | Iron infusion (Feraheme) | $39,016 (2018-2024) | Food & Beverage (55%) | Very High |
| PATEL, NIHAR M.D. | ROUND ROCK | 102,549 | 3,103 | Iron sucrose injection (Venofer) | $180,562 (2018-2024) | Consulting (92%) | Very High |
| NIRMAL, KAVITA M.D. | MARSHALL | 102,468 | 4,656 | Iron infusion (Feraheme) | $1,592 (2018-2024) | Food & Beverage (98%) | Very High |
| SEHGAL, AJAY MD | CORPUS CHRISTI | 101,610 | 1,404 | Nivolumab injection (Opdivo) | $14,123 (2018-2024) | Food & Beverage (87%) | Very High |
| ABBASI-HAFSHEJANI, ELHAM M.D. | THE WOODLANDS | 101,056 | 1,446 | Iron infusion (Feraheme) | $3,430 (2018-2023) | Consulting (94%) | Very High |
| KONDURI, KARTIK MD | DALLAS | 96,810 | 3,286 | Pembrolizumab injection (Keytruda) | $183,738 (2018-2024) | Consulting (53%) | Very High |
| ULMER, SCOTT M.D. | SAN ANTONIO | 96,527 | 4,895 | Iron infusion (Injectafer) | $29,750 (2018-2024) | Consulting (79%) | Very High |
| DALAL, SHAIL MD | PALESTINE | 96,172 | 3,160 | Iron infusion (Feraheme) | $184,926 (2018-2024) | Consulting (64%) | Very High |
| ILLUM, HENRIK M.D. | BEDFORD | 95,992 | 2,926 | Iron sucrose injection (Venofer) | $1,468 (2018-2024) | Food & Beverage (62%) | Very High |
| RIZVI, AKBAR MD | MCKINNEY | 94,092 | 2,869 | Iron sucrose injection (Venofer) | $5,754 (2018-2024) | Food & Beverage (80%) | Very High |
| MEERASAHIB, ANISH M.D. | WEBSTER | 93,974 | 2,861 | Iron infusion (Feraheme) | $5,819 (2018-2024) | Food & Beverage (50%) | Very High |
| KODALI, SRINIVAS M.D | BEAUMONT | 88,663 | 3,916 | Iron sucrose injection (Venofer) | $4,527 (2018-2024) | Food & Beverage (85%) | Very High |
| JOHNSON, CAMILLE M.D. | DENTON | 88,117 | 2,396 | Iron infusion (Feraheme) | $2,437 (2021-2024) | Food & Beverage (66%) | Very High |
| LE, THUY M.D. | PLANO | 85,813 | 2,885 | Iron sucrose injection (Venofer) | $16,393 (2018-2024) | Food & Beverage (58%) | Very High |
| CHALLAGUNDLA, SUNEETHA MD | SAN ANTONIO | 85,778 | 5,674 | Darbepoetin injection (Aranesp) for anemia | $7,979 (2018-2024) | Food & Beverage (91%) | Very High |
| PALANISAMY, NITHYA MD | MCKINNEY | 85,624 | 4,121 | Iron sucrose injection (Venofer) | $8,835 (2018-2024) | Consulting (82%) | Very High |
| JAIN, SHARAD MD | DENTON | 83,167 | 4,263 | Iron infusion (Feraheme) | $27,466 (2018-2024) | Consulting (79%) | Very High |
| GORREBEECK, ALLISON MD | AUSTIN | 81,644 | 3,062 | Iron sucrose injection (Venofer) | $2,700 (2018-2024) | Food & Beverage (93%) | Very High |
| JUTURI, JAYA MD | DALLAS | 80,536 | 4,230 | Iron sucrose injection (Venofer) | $2,582 (2018-2024) | Consulting (35%) | Very High |
| GUO, SHAN M.D. | HOUSTON | 80,315 | 933 | Iron infusion (Injectafer) | $20,996 (2018-2024) | Consulting (46%) | Very High |
| AHMAD, ASIM MD | FORT WORTH | 78,961 | 1,196 | Filgrastim injection (Nivestym) for white blood cells | $83,618 (2018-2024) | Consulting (42%) | Very High |
| REDDY, DHEERAJ M.D | GARLAND | 78,943 | 2,153 | Iron infusion (Feraheme) | $4,738 (2021-2024) | Food & Beverage (80%) | Very High |
| PACHIPALA, KRISHNA M.D. | SHENANDOAH | 77,522 | 1,500 | Iron sucrose injection (Venofer) | $25,698 (2018-2024) | Consulting (51%) | Very High |
Note: Hematology & Oncology encompasses multiple subspecialties with different practice patterns.
Differences in payment amounts and procedure volumes may reflect subspecialty focus
rather than practice quality. Consider viewing individual profiles for full context.